303 related articles for article (PubMed ID: 29903928)
61. Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes.
Moroz MA; Zhang H; Lee J; Moroz E; Zurita J; Shenker L; Serganova I; Blasberg R; Ponomarev V
J Nucl Med; 2015 Jul; 56(7):1055-60. PubMed ID: 26025962
[TBL] [Abstract][Full Text] [Related]
62. Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation.
Guedan S; Posey AD; Shaw C; Wing A; Da T; Patel PR; McGettigan SE; Casado-Medrano V; Kawalekar OU; Uribe-Herranz M; Song D; Melenhorst JJ; Lacey SF; Scholler J; Keith B; Young RM; June CH
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321369
[TBL] [Abstract][Full Text] [Related]
63. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
[TBL] [Abstract][Full Text] [Related]
64. Activated T-cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell non-Hodgkin lymphoma.
Mihara K; Yanagihara K; Takigahira M; Imai C; Kitanaka A; Takihara Y; Kimura A
J Immunother; 2009 Sep; 32(7):737-43. PubMed ID: 19561535
[TBL] [Abstract][Full Text] [Related]
65. Ex Vivo Radiolabeling and In Vivo PET Imaging of T Cells Expressing Nuclear Reporter Genes.
Moroz MA; Zanzonico P; Lee JT; Ponomarev V
Methods Mol Biol; 2018; 1790():153-163. PubMed ID: 29858790
[TBL] [Abstract][Full Text] [Related]
66. Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.
Han X; Cinay GE; Zhao Y; Guo Y; Zhang X; Wang P
Mol Ther; 2017 Nov; 25(11):2466-2476. PubMed ID: 28784559
[TBL] [Abstract][Full Text] [Related]
67. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
68. Monte Carlo simulation of radiation transport and dose deposition from locally released gold nanoparticles labeled with
Lai P; Cai Z; Pignol JP; Lechtman E; Mashouf S; Lu Y; Winnik MA; Jaffray DA; Reilly RM
Phys Med Biol; 2017 Oct; 62(22):8581-8599. PubMed ID: 29077574
[TBL] [Abstract][Full Text] [Related]
69. Imaging and biodistribution of radiolabeled SP90 peptide in BT-483 tumor bearing mice.
Lo WL; Liang CH; Chen LC; Lee SY; Lo SN; Chen MW; Lu RM; Liu IJ; Wu HC; Chang CH
Appl Radiat Isot; 2020 Jul; 161():109162. PubMed ID: 32561130
[TBL] [Abstract][Full Text] [Related]
70. Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT.
Hoffmann SHL; Maurer A; Reck DI; Reischl G; Pichler BJ; Kneilling M; Griessinger CM
J Vis Exp; 2017 Apr; (122):. PubMed ID: 28518105
[TBL] [Abstract][Full Text] [Related]
71. Chimeric Antigen Receptors Based on Low Affinity Mutants of FcεRI Re-direct T Cell Specificity to Cells Expressing Membrane IgE.
Ward DE; Fay BL; Adejuwon A; Han H; Ma Z
Front Immunol; 2018; 9():2231. PubMed ID: 30364107
[TBL] [Abstract][Full Text] [Related]
72. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
[TBL] [Abstract][Full Text] [Related]
73. Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.
Mensali N; Myhre MR; Dillard P; Pollmann S; Gaudernack G; Kvalheim G; Wälchli S; Inderberg EM
Cancer Immunol Immunother; 2019 Aug; 68(8):1235-1243. PubMed ID: 31214732
[TBL] [Abstract][Full Text] [Related]
74. Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications.
Kurtz K; Eibler L; Dacek MM; Carter LM; Veach DR; Lovibond S; Reynaud E; Qureshy S; McDevitt MR; Bourne C; Monette S; Punzalan B; Khayat S; Verma S; Kesner AL; Cheung NV; Schöder H; Gajecki L; Cheal SM; Larson SM; Scheinberg DA; Krebs S
Theranostics; 2023; 13(15):5469-5482. PubMed ID: 37908719
[No Abstract] [Full Text] [Related]
75. Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.
Kim M; Pyo S; Kang CH; Lee CO; Lee HK; Choi SU; Park CH
PLoS One; 2018; 13(6):e0198347. PubMed ID: 29874279
[TBL] [Abstract][Full Text] [Related]
76. Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of (177)Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor-positive prostate tumor targeting.
Lim JC; Cho EH; Kim JJ; Choi SM; Lee SY; Nam SS; Park UJ; Park SH
Nucl Med Biol; 2015 Mar; 42(3):234-41. PubMed ID: 25498002
[TBL] [Abstract][Full Text] [Related]
77. Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy.
Urak R; Walter M; Lim L; Wong CW; Budde LE; Thomas S; Forman SJ; Wang X
J Immunother Cancer; 2017; 5():26. PubMed ID: 28331616
[TBL] [Abstract][Full Text] [Related]
78. A Transgenic Dual-Luciferase Reporter Mouse for Longitudinal and Functional Monitoring of T Cells
Szyska M; Herda S; Althoff S; Heimann A; Russ J; D'Abundo D; Dang TM; Durieux I; Dörken B; Blankenstein T; Na IK
Cancer Immunol Res; 2018 Jan; 6(1):110-120. PubMed ID: 29259004
[TBL] [Abstract][Full Text] [Related]
79. PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models.
Zuccolotto G; Fracasso G; Merlo A; Montagner IM; Rondina M; Bobisse S; Figini M; Cingarlini S; Colombatti M; Zanovello P; Rosato A
PLoS One; 2014; 9(10):e109427. PubMed ID: 25279468
[TBL] [Abstract][Full Text] [Related]
80. Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.
Brown CE; Aguilar B; Starr R; Yang X; Chang WC; Weng L; Chang B; Sarkissian A; Brito A; Sanchez JF; Ostberg JR; D'Apuzzo M; Badie B; Barish ME; Forman SJ
Mol Ther; 2018 Jan; 26(1):31-44. PubMed ID: 29103912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
